- Investing Ideas
- Chinese Pharmaceuticals & Biotech High Return On Equity, Low Debt
Chinese Pharmaceuticals & Biotech High Return On Equity, Low Debt
Results
3
0 new
Stocks with a return on equity of over 30% and a debt to equity ratio below 1.
3 companies
Shanghai Allist Pharmaceuticals
Market Cap: CN¥49.1b
A pharmaceutical company, engages in the research and development of tumor-targeted drugs in China in internationally.
688578
CN¥125.81
7D
34.6%
1Y
33.3%
Sunshine Guojian Pharmaceutical (Shanghai)
Market Cap: CN¥47.6b
A biopharmaceutical company, engages in the research and development, production, and sale of antibody drugs.
688336
CN¥58.50
7D
36.4%
1Y
59.1%
Shenyang Xingqi PharmaceuticalLtd
Market Cap: CN¥14.6b
Engages in the research, development, production, and sale of ophthalmic drugs in the People’s Republic of China.
300573
CN¥42.66
7D
8.1%
1Y
19.5%